Get the Stockscreener App
26.03
0.70%
0.18
After Hours:
26.20
0.17
+0.65%
Staar Surgical Co stock is traded at $26.03, with a volume of 391.99K.
It is up +0.70% in the last 24 hours and down -4.48% over the past month.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
See More
Previous Close:
$25.85
Open:
$25.7
24h Volume:
391.99K
Relative Volume:
0.40
Market Cap:
$1.28B
Revenue:
$224.45M
Net Income/Loss:
$-95.27M
P/E Ratio:
-13.49
EPS:
-1.93
Net Cash Flow:
$-43.74M
1W Performance:
-2.25%
1M Performance:
-4.48%
6M Performance:
+37.00%
1Y Performance:
-8.47%
1-Day Range:
$25.66
$26.24
1-Week Range:
$24.59
$27.52
52-Week Range:
$13.50
$30.81
Staar Surgical Co Stock (STAA) Company Profile
Name
Staar Surgical Co
Sector
Industry
Phone
(626) 303-7902
Address
1911 WALKER AVE, MONROVIA, CA
Compare STAA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
26.03 | 1.28B | 224.45M | -95.27M | -43.74M | -1.93 |
|
ISRG
Intuitive Surgical Inc
|
565.51 | 202.93B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.07B | 21.84B | 1.68B | 2.55B | 5.8322 |
|
ALC
Alcon Inc
|
78.61 | 39.02B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
252.11 | 36.91B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
266.66 | 19.70B | 2.96B | 487.70M | 344.00M | 6.6758 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-25 | Initiated | Wells Fargo | Equal Weight |
| Feb-12-25 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-12-25 | Downgrade | Jefferies | Buy → Hold |
| Feb-12-25 | Downgrade | Mizuho | Outperform → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-11-24 | Upgrade | BTIG Research | Neutral → Buy |
| Mar-11-24 | Upgrade | Stifel | Hold → Buy |
| Dec-05-23 | Downgrade | Needham | Buy → Hold |
| Dec-04-23 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-03-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jun-07-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-17-23 | Initiated | Piper Sandler | Neutral |
| Feb-06-23 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-28-22 | Reiterated | BTIG Research | Buy |
| Dec-08-22 | Initiated | Stifel | Hold |
| Nov-07-22 | Upgrade | Sidoti | Neutral → Buy |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-28-22 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-18-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-09-21 | Initiated | Oppenheimer | Perform |
| Jan-19-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-26-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-31-20 | Upgrade | Sidoti | Neutral → Buy |
| Aug-06-20 | Reiterated | The Benchmark Company | Buy |
| Jul-06-20 | Downgrade | Sidoti | Buy → Neutral |
| Jun-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-15-20 | Initiated | Jefferies | Buy |
| Dec-04-19 | Initiated | BTIG Research | Buy |
| Sep-24-18 | Reiterated | The Benchmark Company | Buy |
| Aug-06-18 | Resumed | The Benchmark Company | Buy |
| Nov-20-17 | Reiterated | The Benchmark Company | Buy |
| Aug-14-17 | Reiterated | The Benchmark Company | Buy |
| Mar-03-17 | Reiterated | The Benchmark Company | Buy |
| May-18-16 | Upgrade | The Benchmark Company | Hold → Buy |
| Sep-10-13 | Resumed | The Benchmark Company | Buy |
| Feb-28-13 | Reiterated | The Benchmark Company | Buy |
| Nov-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-12 | Initiated | Northland Securities | Outperform |
| Oct-25-11 | Reiterated | The Benchmark Company | Buy |
| Oct-12-10 | Initiated | Morgan Joseph | Buy |
| May-11-10 | Initiated | Benchmark | Buy |
View All
Staar Surgical Co Stock (STAA) Latest News
Alcon reports strong 3Q, unsure about Staar merger - BioWorld MedTech
Intraocular Lens Market Size to Generate CAGR of ~5-6% By 2026 : Medi-Tech Insights - PharmiWeb.com
Exclusive: Broadwood says Alcon’s earnings reveal STAAR bid came from ‘weakness’ - Investing.com Canada
Midday Stock Roundup: Eledon falls 14% - Orange County Business Journal
Midday Stock Roundup: Viant Tech Jumps on Earnings - Orange County Business Journal
Keep An Eye On AlconSetting Sights On Future Gains - RTTNews
Alcon Earns Investor Relief With Steady Outlook And Rising Sales - Finimize
Broadwood criticizes STAAR’s merger process with Alcon By Investing.com - Investing.com Nigeria
Broadwood Partners Calls for the Appointment of New Directors at STAAR Surgical - citybiz
STAAR’s largest shareholder requests new directors in ongoing Alcon merger dispute - Yahoo Finance
Broadwood Partners Calls for the Appointment of New Directors at STAAR Surgical to Oversee Go-Shop Process - MarketScreener
STAAR Surgical (STAA): Exploring Current Valuation Perspectives After Recent Share Price Stability - Yahoo Finance
STAAR Surgical Company (STAA) Stock forecasts - Yahoo Finance UK
STAAR Surgical opens go-shop window amid shareholder revolt over Alcon deal - Investing.com
STAAR Surgical (STAA) Amends Alcon Merger Agreement with Go-Shop Period - GuruFocus
STAAR Surgical (NASDAQ: STAA) sets 30-day go-shop; Alcon waives matching rights - Stock Titan
Yunqi Capital opposes Alcon’s acquisition of STAAR Surgical By Investing.com - Investing.com Nigeria
Yunqi Capital opposes Alcon’s acquisition of STAAR Surgical - Investing.com
Yunqi Capital Applauds STAAR Surgical’s Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated - Placera.se
Staar Surgical: Q3 Earnings Snapshot - ctinsider.com
Decoding Staar Surgical Co (STAA): A Strategic SWOT Insight - GuruFocus
STAAR Surgical Company (STAA) Stock Forecasts - Yahoo Finance
STAAR Surgical’s Q3 Sales Climb Despite Profit Dip And Uncertainty - Finimize
Staar Surgical Co (STAA) Q3 2025 Earnings: EPS of $0.18 Beats Es - GuruFocus
STAAR Surgical Reports Third Quarter 2025 Results - Yahoo Finance Singapore
Broadwood urges STAAR shareholders to reject Alcon acquisition By Investing.com - Investing.com Australia
STAAR Surgical earnings matched, revenue topped estimates - Investing.com
Is STAAR Surgical Company stock vulnerable to regulatory risksJuly 2025 Decliners & Daily Stock Trend Reports - newser.com
Is STAAR Surgical Company stock entering bullish territoryQuarterly Market Summary & Risk Managed Investment Strategies - newser.com
Alcon, Broadwood trade blows in fight for STAAR Surgical’s future By Investing.com - Investing.com Nigeria
Alcon, Broadwood trade blows in fight for STAAR Surgical’s future - Investing.com
Broadwood urges STAAR shareholders to reject Alcon acquisition - Investing.com
Broadwood Partners Condemns Alcon’s Fallacious Attacks on STAAR Surgical and Its Prospects - Stock Titan
Alcon stock outlook remains positive as Bernstein reiterates Outperform rating - Investing.com
Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders - Stock Titan
Wells Fargo Initiates Coverage of STAAR Surgical (STAA) with Equal-Weight Recommendation - MSN
[DFAN14A] STAAR SURGICAL CO SEC Filing - Stock Titan
Will STAAR Surgical Company stock benefit from AI adoptionWeekly Trend Recap & AI Based Buy and Sell Signals - newser.com
Can STAAR Surgical Company stock rebound after recent weaknessWeekly Investment Summary & AI Optimized Trade Strategies - newser.com
Key deals this week: STAAR Surgical, Pfizer, DB Insurance, Strive, Rocket Lab and more - MSN
Yunqi Capital criticizes STAAR’s postponement of Alcon deal vote By Investing.com - Investing.com Australia
Staar Surgical Shares Slip After Alcon Refuses To Reconsider Merger Consideration - MSN
Yunqi Capital criticizes STAAR’s postponement of Alcon deal vote - Investing.com
Midday Stock Roundup: BJ’s Surges After Earnings top Estimates - Orange County Business Journal
Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon - Stock Titan
Staar Surgical Co Stock (STAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
1.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):